Ranking · Brussels · NACE 21

Manufacture of basic pharmaceutical products and pharmaceutical preparations: highest revenue in Brussels

As of 13 Nov 2026, 19 companies in Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21) in Brussels publish their revenue in recent accounts (financial years 2025 to 2026). The top 10 account for €9.37bn, out of €9.49bn for all of them; median revenue is €39.7m. UCB Pharma leads with €4.62bn (financial year 2025).

Top 19 · Manufacture of basic pharmaceutical products and pharmaceutical preparations · Brussels

Ranked by revenue published in the latest filed accounts (accounts less than 3 years old).

#Company Total assetsRevenue EquityFTEYear
1 UCB Pharma 1070 Anderlecht €20.7bn €4.62bn €16.2bn 1,960.6 2025
2 UCB Biopharma 1070 Anderlecht €7.15bn €2.04bn €1.18bn 1,395.2 2025
3 PHOENIX Pharma Belgium 1200 Woluwe-Saint-Lambert €235.4m €1.33bn €46.5m 496.7 2026
4 Roche 1070 Anderlecht €164.7m €448.8m €64.5m 122.7 2025
5 Pfizer 1050 Ixelles €377.4m €358.3m €129.1m 297.0 2025
6 Novo Nordisk Production Belgium SA 1120 Brussels €153.5m €246.3m €74.2m 587.2 2025
7 Laboratoires S.M.B. 1080 Molenbeek-Saint-Jean €261.5m €112.5m €172.9m 40.0 2025
8 Prothya Biosolutions Belgium 1120 Brussels €134.4m €109.1m −€2.24m 349.0 2026
9 Ipsen 1000 Brussels €134.4m €71.3m €119.9m 39.9 2025
10 Besins Manufacturing Belgium 1050 Ixelles €19.1m €39.7m €7.92m 104.7 2025
11 Sofarmex 1200 Woluwe-Saint-Lambert €5.23m €30.0m €4.50m — 2026
12 Alexion Pharma Belgium 1000 Brussels €8.68m €20.8m €3.44m 9.3 2025
13 Ferring 1070 Anderlecht €11.0m €20.4m €3.09m 13.8 2025
14 Laboratoires Sterop 1070 Anderlecht €23.9m €17.3m €8.03m 101.5 2025
15 Boiron 1140 Evere €9.25m €12.2m €6.59m 59.7 2025
16 Departement Central de Fractionnement 1120 Brussels €19.7m €11.2m €18.7m 13.2 2025
17 Betaplus Pharma 1200 Woluwe-Saint-Lambert €24.9m €5.41m €22.3m 11.3 2025
18 Parc Elisabeth Pharma 1083 Ganshoren 296,304 € 491,912 € −63,400 € — 2025
19 Le Groupe Odin 1050 Ixelles 571,856 € 81,250 € 567,848 € — 2025

Ranking based on each company's own annual accounts (statutory, not consolidated): a subsidiary and its parent appear separately, and the ranking differs from lists based on consolidated group accounts. These are the revenue figures published in the annual accounts. Small companies (micro and abridged accounts) do not have to publish theirs: they do not appear in this ranking.

Manufacture of basic pharmaceutical products and pharmaceutical preparations across Belgium → All sectors · Brussels →

Other sectors · Brussels

Municipalities with the most companies in the sector · Brussels

Frequently asked questions

Which company in Manufacture of basic pharmaceutical products and pharmaceutical preparations in Brussels has the highest revenue?

UCB Pharma, with €4.62bn of published revenue (financial year 2025).

Why are some companies missing?

Small companies (micro and abridged accounts) do not have to publish their revenue: only the 19 that publish it, out of 83 companies in the sector in the area, are ranked.

Why does this ranking differ from other lists?

It uses each company's annual accounts as filed with the National Bank, not consolidated group accounts. A holding, a subsidiary or a purchasing entity can therefore appear separately. Only companies whose latest accounts are less than 3 years old are ranked.

Idonis

Analyse companies · Brussels

Filter these companies by size, soundness and trend, follow them and get an alert when their accounts or publications change.

Open the full file →
Free account in 30 seconds, by email. No bank card.

Active companies (legal entities) that have filed at least one set of annual accounts, based on the Crossroads Bank for Enterprises and the National Bank of Belgium. The sector is the main activity in the register; the municipality is that of the registered office. Data updated on 13 Nov 2026.